FDA Warns on Needle-Free Injection Devices for Facial Fillers Serious injuries and "irreversible" harm to skin, lips, and eyes reported with unapproved devices Oct 08, 2021
FDA Gives Thumbs Up to ANCA-Associated Vasculitis Drug Approval granted to avacopan despite advisory committee concerns Oct 08, 2021
Back-to-Back Recalls for Medtronic Insulin Pumps Class I recalls on 600 series pumps and 500 series remotes Oct 06, 2021
FDA Clears 'Major Advancement' in CT Imaging New Siemens' CT scanner is first allowed by agency with photon-counting detectors Sep 30, 2021
The Cost of Blood Platelets Is About to Surge FDA's flawed new guidance for blood transfusion safety takes effect October 1 Sep 30, 2021
How Many Deaths Will New Cigarette Warnings Prevent? Modeling study comes up with big numbers Sep 24, 2021
FDA Approves First Topical JAK Inhibitor for Atopic Dermatitis Significant skin clearance, reduced itch in majority of patients treated with ruxolitinib cream Sep 22, 2021
Unapproved Drug Found in Dietary Supplements Despite FDA Warning Phenibut was found in all four products analyzed, with increased quantities in three Sep 22, 2021
Pipeline Flex Endovascular Flow Diverters Under Recall Serious injury and death linked to fracturing issue in the delivery system, FDA warns Sep 21, 2021
The Technological Marvel of Combination Vaccines Many questions remain for co-formulating COVID vaccines, but pursuing this now is the right move Sep 18, 2021
Pfizer Makes Its Case for COVID Booster Shots Ahead of advisory meeting, FDA staff notes "inferred" effectiveness, and no new safety concerns Sep 15, 2021
Gene Therapies Require Neurologic Monitoring Nerve conduction, MRI monitoring may mitigate neurotoxicity risks Sep 07, 2021
Liver Toxicity in Gene Therapy Trials Could Merit Stricter Entry Criteria FDA panel weighs in on lower vector doses and role of animal studies Sep 03, 2021
Take Another Look at the Spacing Between COVID Vaccine Doses Growing body of research suggests robust immune response with extended dosing interval Sep 01, 2021
FDA Slaps Restrictions on JAK Inhibitors Over Serious Safety Risks Use for inflammatory conditions limited to those who fail on TNF blockers Sep 01, 2021
Novel Stroke Rehab Treatment Wins FDA Approval Neurostim system approved for upper limb deficits Aug 27, 2021
FDA Warns on Contamination Risk With Eco-Med Ultrasound Gels Healthcare providers must toss all of company's gels and lotions, agency says Aug 19, 2021
FDA Grants Tissue-Agnostic Approval to Dostarlimab for dMMR Tumors Overall response rate of 41.6% in various tumor types with mismatch repair deficiency Aug 18, 2021
Notice Any Rule Changes in Washington? You Can Thank COVID "It's opened a Pandora's box, which is not going back" Aug 11, 2021
CMS Proposes to Rescind 'Most Favored Nation' Drug Pricing Rule Regulation from Trump administration had been barred from taking effect due to court challenges Aug 09, 2021
All Eyes on FDA: The Upcoming Regulation of Juul E-Cigarettes Will the public health be protected? Aug 06, 2021
TAVR Debris Deflector Doesn't Fly With FDA Advisory Panel TriGuard 3 met with skepticism in its bid for approval Aug 04, 2021
Monoclonal Antibody Cocktail Authorized for Post-COVID Exposure REGEN-COV becomes first monoclonal antibody treatment with EUA following exposure alone Jul 30, 2021
Call in the T-Cell Cavalry to Fight COVID in the Immunocompromised Preliminary research suggests immunotherapy could play role in protecting vaccine non-responders Jul 29, 2021
More Medical Device Deaths Than We Previously Thought? Study finds many reports of patient deaths that were not classified as a death in FDA database Jul 27, 2021
Shingrix OK'd for Immunocompromised Adults CDC's vaccine committee currently discussing vaccine for this population, manufacturer says Jul 26, 2021
FDA Approves IVIG for Dermatomyositis Octagam 10% lands indication for adults following results of ProDERM trial Jul 20, 2021
FDA Warns Doctors, Consumers on Contaminated Chantix Latest drug found with cancer-causing nitrosamines Jul 20, 2021
FDA Breaks New Ground With Transplant Drug Approval No prospective trial offered or required Jul 19, 2021
Safety Concerns Turn FDA Panel Thumbs Down for Novel CKD-Anemia Drug Advisory committee rejected oral anemia drug for dialysis and non-dialysis patient populations Jul 16, 2021
FDA Panel Nearly Unanimous on Liver Transplant Perfusion Device Thumbs up on safety and efficacy Jul 15, 2021
Company Shut Down Robot Mid-Surgery; Infected in Quarantine; Investigating Aduhelm This past week in healthcare investigations Jul 14, 2021
Juul Bought Out Medical Journal for $51K E-cig maker sponsored nearly a dozen studies, took over journal as it awaits FDA ruling Jul 13, 2021
Ivermectin and Aducanumab: Do They Work? ZDoggMD and Vinay Prasad, MD, MPH, analyze the evidence Jul 13, 2021
Walmart's Low-Price Insulin Is a Band-Aid on a Broken System Exorbitant drug pricing and inaccessible care require government intervention Jul 11, 2021
Finerenone OK'd for Slowing Kidney Disease in T2D Drug also indicated for cardiovascular event risk reduction Jul 09, 2021
Alzheimer's Aducanumab Prescribing Information Changes "We as neurologists need a strategy to advise our patients," experts say Jul 09, 2021
FDA Cannot Ban Use of Electric Shock Devices for Harmful Behaviors Appeals court rules in favor of only U.S. facility still using devices for behavioral treatment Jul 09, 2021